GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » EV-to-FCF

Aptorum Group (Aptorum Group) EV-to-FCF : -3.53 (As of May. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Aptorum Group's Enterprise Value is $27.27 Mil. Aptorum Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.73 Mil. Therefore, Aptorum Group's EV-to-FCF for today is -3.53.

The historical rank and industry rank for Aptorum Group's EV-to-FCF or its related term are showing as below:

APM' s EV-to-FCF Range Over the Past 10 Years
Min: -55.77   Med: -3.07   Max: 0.21
Current: -3.53

During the past 7 years, the highest EV-to-FCF of Aptorum Group was 0.21. The lowest was -55.77. And the median was -3.07.

APM's EV-to-FCF is ranked worse than
100% of 379 companies
in the Biotechnology industry
Industry Median: 8.34 vs APM: -3.53

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Aptorum Group's stock price is $4.83. Aptorum Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.620. Therefore, Aptorum Group's PE Ratio for today is At Loss.


Aptorum Group EV-to-FCF Historical Data

The historical data trend for Aptorum Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group EV-to-FCF Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -31.67 -3.18 -2.65 -1.33 -0.58

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.65 - -1.33 - -0.58

Competitive Comparison of Aptorum Group's EV-to-FCF

For the Biotechnology subindustry, Aptorum Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptorum Group's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Aptorum Group's EV-to-FCF falls into.



Aptorum Group EV-to-FCF Calculation

Aptorum Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=27.266/-7.727
=-3.53

Aptorum Group's current Enterprise Value is $27.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptorum Group  (NAS:APM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Aptorum Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.83/-0.620
=At Loss

Aptorum Group's share price for today is $4.83.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.620.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Aptorum Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Aptorum Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines

From GuruFocus

Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris

By Business Wire Business Wire 06-09-2023